Danshen Improves Survival of Patients With Breast Cancer and Dihydroisotanshinone I Induces Ferroptosis and Apoptosis of Breast Cancer Cells
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Danshen Improves Survival of Patients With Breast Cancer and Dihydroisotanshinone I Induces Ferroptosis and Apoptosis of Breast Cancer Cells
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-10-31
DOI
10.3389/fphar.2019.01226
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Salvia miltiorrhiza in Treating Cardiovascular Diseases: A Review on Its Pharmacological and Clinical Applications
- (2019) Jie Ren et al. Frontiers in Pharmacology
- Ethnopharmacology, phytochemistry, and pharmacology of Chinese Salvia species: A review
- (2018) Jianping Xu et al. JOURNAL OF ETHNOPHARMACOLOGY
- Cytotoxicity of Tanshinone IIA combined with Taxol on drug-resist breast cancer cells MCF-7 through inhibition of Tau
- (2018) Hui Lin et al. PHYTOTHERAPY RESEARCH
- The antitumor natural product tanshinone IIA inhibits protein kinase C and acts synergistically with 17-AAG
- (2018) Chao Lv et al. Cell Death & Disease
- Role of GPX4 in ferroptosis and its pharmacological implication
- (2018) Tobias M. Seibt et al. FREE RADICAL BIOLOGY AND MEDICINE
- Tanshinone-IIA-Based Analogues of Imidazole Alkaloid Act as Potent Inhibitors To Block Breast Cancer Invasion and Metastasis in Vivo
- (2018) Qiong Wu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Role of Mitochondria in Ferroptosis
- (2018) Minghui Gao et al. MOLECULAR CELL
- Danshen improves survival of patients with colon cancer and dihydroisotanshinone I inhibit the proliferation of colon cancer cells via apoptosis and skp2 signaling pathway
- (2017) Yin-Yin Lin et al. JOURNAL OF ETHNOPHARMACOLOGY
- Anti-cancer effect of danshen and dihydroisotanshinone I on prostate cancer: targeting the crosstalk between macrophages and cancer cells via inhibition of the STAT3/CCL2 signaling pathway
- (2017) Ching-Yuan Wu et al. Oncotarget
- Danshen improves survival of patients with advanced lung cancer and targeting the relationship between macrophages and lung cancer cells
- (2017) Ching-Yuan Wu et al. Oncotarget
- Reproductive toxicity after levetiracetam administration in male rats: Evidence for role of hormonal status and oxidative stress
- (2017) Merve Baysal et al. PLoS One
- Ferroptosis: Death by Lipid Peroxidation
- (2016) Wan Seok Yang et al. TRENDS IN CELL BIOLOGY
- Glutathione peroxidase 4 prevents necroptosis in mouse erythroid precursors
- (2015) O. Canli et al. BLOOD
- Statin use and the risk of cirrhosis development in patients with hepatitis C virus infection
- (2015) Yao-Hsu Yang et al. JOURNAL OF HEPATOLOGY
- The potential utility of acetyltanshinone IIA in the treatment of HER2-overexpressed breast cancer: Induction of cancer cell death by targeting apoptotic and metabolic signaling pathways
- (2015) Mounia Guerram et al. Oncotarget
- Tanshinone IIA Inhibits HIF-1α and VEGF Expression in Breast Cancer Cells via mTOR/p70S6K/RPS6/4E-BP1 Signaling Pathway
- (2015) Guobing Li et al. PLoS One
- Adjunctive traditional Chinese medicine therapy improves survival in patients with advanced breast cancer: A population-based study
- (2014) Yuan-Wen Lee et al. CANCER
- Regulation of Ferroptotic Cancer Cell Death by GPX4
- (2014) Wan Seok Yang et al. CELL
- Essential versus accessory aspects of cell death: recommendations of the NCCD 2015
- (2014) L Galluzzi et al. CELL DEATH AND DIFFERENTIATION
- Regulation of the cell cycle and PI3K/Akt/mTOR signaling pathway by tanshinone I in human breast cancer cell lines
- (2014) LI WANG et al. Molecular Medicine Reports
- Tanshinone IIA blocks epithelial-mesenchymal transition through HIF-1α downregulation, reversing hypoxia-induced chemotherapy resistance in breast cancer cell lines
- (2014) PEIFEN FU et al. ONCOLOGY REPORTS
- Coprescription of Chinese herbal medicine and Western medication among female patients with breast cancer in Taiwan: analysis of national insurance claims
- (2014) Yueh-Ching Chou et al. Patient Preference and Adherence
- Tanshinone IIA inhibits breast cancer stem cells growth in vitro and in vivo through attenuation of IL-6/STAT3/NF-kB signaling pathways
- (2013) Caiyu Lin et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Tanshinone IIA inhibits BT-20 human breast cancer cell proliferation through increasing caspase 12, GADD153 and phospho-p38 protein expression
- (2012) Chin-Cheng Su INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Tanshinone IIA inhibits human breast cancer MDA-MB-231 cells by decreasing LC3-II, Erb-B2 and NF-κBp65
- (2012) CHIN-CHENG SU et al. Molecular Medicine Reports
- Tanshinones Inhibit the Growth of Breast Cancer Cells through Epigenetic Modification of Aurora A Expression and Function
- (2012) Yi Gong et al. PLoS One
- Use of Chinese medicine by women with breast cancer: A nationwide cross-sectional study in Taiwan
- (2011) Yi-Hsien Lin et al. COMPLEMENTARY THERAPIES IN MEDICINE
- A novel compound modified from tanshinone inhibits tumor growth in vivo via activation of the intrinsic apoptotic pathway
- (2010) Hong-Lei Tian et al. CANCER LETTERS
- Tanshinone I suppresses growth and invasion of human breast cancer cells, MDA-MB-231, through regulation of adhesion molecules
- (2008) I. T. Nizamutdinova et al. CARCINOGENESIS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search